{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T23:04:02Z","timestamp":1767135842571,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd010253","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,6,5]],"date-time":"2014-06-05T00:00:00Z","timestamp":1401926400000}}],"reference-count":117,"publisher":"Wiley","issue":"7","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010253.pub2","type":"journal-article","created":{"date-parts":[[2014,6,5]],"date-time":"2014-06-05T15:39:30Z","timestamp":1401982770000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Antibody induction versus placebo, no induction, or another type of antibody induction for liver transplant recipients"],"prefix":"10.1002","volume":"2014","author":[{"given":"Luit","family":"Penninga","sequence":"first","affiliation":[{"name":"Rigshospitalet, Copenhagen University Hospital; Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812; Blegdamsvej 9 Copenhagen Denmark DK-2100"},{"name":"Rigshospitalet, Copenhagen University Hospital; Department of Surgery and Transplantation C2122; Blegdamsvej 9 Copenhagen Denmark DK-2100 \u00d8"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Wettergren","sequence":"additional","affiliation":[{"name":"Surgical Clinic Hvidovre; Hvidovrevej 342, 1. floor Hvidovre Denmark 2650"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin H","family":"Wilson","sequence":"additional","affiliation":[{"name":"The Freeman Hospital; Institute of Transplantation; Freeman Road High Heaton Newcastle upon Tyne Tyne and Wear UK NE7 7DN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An-Wen","family":"Chan","sequence":"additional","affiliation":[{"name":"University of Toronto; Women's College Research Institute; 790 Bay St, Rm 735 Toronto ON Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel A","family":"Steinbr\u00fcchel","sequence":"additional","affiliation":[{"name":"Rigshospitalet, Copenhagen University Hospital; Department of Cardiothoracic Surgery; Blegdamsvej 9 Copenhagen Denmark DK-2100"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Gluud","sequence":"additional","affiliation":[{"name":"Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital; The Cochrane Hepato-Biliary Group; Blegdamsvej 9 Copenhagen Denmark DK-2100"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,6,5]]},"reference":[{"key":"10.1002\/14651858.CD010253.pub2-BIB0001|cit1","doi-asserted-by":"crossref","unstructured":"Bogetti D Jarzembowski T-M Sankary H-N Manzelli A Knight P-S Chejfec G Hepatic ischemia\/reperfusion injury can be modulated with thymoglobulin induction therapy Transplantation Proceedings 2005 404 6","DOI":"10.1016\/j.transproceed.2004.12.064"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0002|cit2","doi-asserted-by":"crossref","unstructured":"Bogetti D Sankary HN Chejfec G Cotler S Testa G Benedetti E Thymoglobulin (TG) induction protects liver allografts from ischemia\/reperfusion injury (IRI) American Journal of Transplantation 2004 25","DOI":"10.1111\/j.1399-0012.2005.00375.x"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0003|cit3","unstructured":"Boillot O Poncet G M\u00e9chet I Dumortier J Delafosse B Sagnard P Randomized trial of triple based immunosuppression using tacrolimus, mycophenolate mofetil and steroids quadruple regimen induction with thymoglobulin in liver transplantation Hepatology 2000 599A"},{"issue":"11","key":"10.1002\/14651858.CD010253.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/lt.21905","article-title":"Thymoglobulin induction in liver transplant recipients with a tacrolimus, mycophenolate mofetil, and steroid immunosuppressive regimen: a five-year randomized prospective study","volume":"15","author":"Boillot","year":"2009","journal-title":"Liver Transplantation"},{"issue":"12","key":"10.1002\/14651858.CD010253.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1097\/TP.0b013e3181db8cf0","article-title":"Assessing renal function with daclizumab induction and delayed tacrolimus introduction in liver transplant recipients","volume":"89","author":"Calmus","year":"2010","journal-title":"Transplantation"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0006|cit6","doi-asserted-by":"crossref","unstructured":"Cosimi AB Jenkins RL Rohrer RJ Delmonico FL Hoffman M Monaco AP A randomized clinical trial of prophylactic OKT3 monoclonal antibody in liver allograft recipients Archives of Surgery 1990 781 4","DOI":"10.1001\/archsurg.1990.01410180107017"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0007|cit7","unstructured":"Eghtesad B Forrest T Fijiki M Diago T Hodgkinson P Hashimoto K A pilot randomized controlled clinical trial of thymoglobulin (r-ATG) induction with extended delay of calcineurin inhibitor therapy in liver transplantation - Interim analysis International Liver Transplant Society 2011 O 21"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0008|cit8","doi-asserted-by":"crossref","unstructured":"Farges O Ericzon BG Bresson Hadni S Lynch SV Hockerstedt K Houssin D A randomized trial of OKT3-based versus cyclosporine-based immunoprophylaxis after liver transplantation. Long-term results of a European and Australian multicenter study Transplantation 1994 891 8","DOI":"10.1097\/00007890-199410270-00006"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0009|cit9","unstructured":"Farges O Ericzon BG Miguet JP Lynch S Hockerstedt K Chapuis Y [Immunoprophylaxis with OKT3 after hepatic transplantation: results of a multicenter, prospective, controlled study] Annales de Chirurgie 1993 675"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0010|cit10","first-page":"C","article-title":"Daclizumab (DZB) induction in adult hepatitis C (HCV) liver transplant recipients (OLT): a single center experience with different antibody doses","volume":"11","author":"Fasola","year":"2005","journal-title":"Liver Transplantation"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0011|cit11","first-page":"99","article-title":"Interleukin-2 receptor antibody versus ATG for induction immunosuppression after liver transplantation: results of a prospective randomized trial","volume":"379","author":"Bechstein","year":"1994","journal-title":"Langenbecks Archiv f\u00fcr Chirurgie"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0012|cit12","unstructured":"Langrehr J Guckelberger O Neumann U Nussler N Lobeck H Lohmann R A randomized trial comparing quadruple induction therapy with ANTI-IL-2 receptor antibody or ATG after liver transplantation, 1997 www.astp.org (accessed 12 April 2012)"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0013|cit13","first-page":"673","article-title":"Quadruple induction therapy following liver transplantation with interleukin-2 receptor antibody BT563 or ATG. A prospective randomized trial","volume":"Suppl 1 Forumba","author":"Langrehr","year":"1997","journal-title":"Langenbecks Archiv fur Chirurgie"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0014|cit14","doi-asserted-by":"crossref","unstructured":"Langrehr JM Guckelberger O Nussler N Radtke A Lemmens HP Jonas S Interleukin-2 receptor antibody versus antithymocyte globulin as part of quadruple induction therapy after orthotopic liver transplantation: a randomized study Transplantation Proceedings 1996 3204","DOI":"10.1097\/00007890-199706270-00012"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0015|cit15","doi-asserted-by":"crossref","unstructured":"Langrehr JM Nussler NC Neumann U Guckelberger O Lohmann R Radtke A A prospective randomized trial comparing interleukin-2 receptor antibody versus antithymocyte globulin as part of a quadruple immunosuppressive induction therapy following orthotopic liver transplantation Transplantation 1997 1772 81","DOI":"10.1097\/00007890-199706270-00012"},{"issue":"5","key":"10.1002\/14651858.CD010253.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/S0041-1345(98)00572-7","article-title":"Anti-IL-2 receptor BT563 versus placebo: a randomized trial for induction therapy after liver transplantation","volume":"30","author":"Glanemann","year":"1998","journal-title":"Transplantation Proceedings"},{"issue":"4","key":"10.1002\/14651858.CD010253.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1399-0012.1998.tb00974.x","article-title":"A randomized, placebo-controlled trial with anti-interleukin-2 receptor antibody for immunosuppressive induction therapy after liver transplantation","volume":"12","author":"Langrehr","year":"1998","journal-title":"Clinical Transplantation"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0018|cit18","doi-asserted-by":"crossref","unstructured":"Langrehr JM Glanemann M Schneller A Neumann U Guckelberger O Lohmann R A randomized trial comparing anti-interleukin-2 receptor antibody and placebo for immunosuppressive therapy after OLT Transplantation Proceedings 1998 1445 6","DOI":"10.1016\/S0041-1345(98)00309-1"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1097\/01.TP.0000173996.81192.F9","article-title":"Anti-CD2 monoclonal antibody and tacrolimus in adult liver transplantation","volume":"80","author":"Lerut","year":"2005","journal-title":"Transplantation"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0020|cit20","doi-asserted-by":"crossref","unstructured":"McDiarmid SV Busuttil RW Levy P Millis MJ Terasaki PI Ament ME The long-term outcome of OKT3 compared with cyclosporine prophylaxis after liver transplantation Transplantation 1991 91 7","DOI":"10.1097\/00007890-199107000-00019"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1399-0012.1991.tb00080.x","article-title":"Induction of immunosuppression in pediatric orthotopic liver transplantation","volume":"5","author":"McDiarmid","year":"1991","journal-title":"Clinical Transplantation"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0022|cit22","doi-asserted-by":"crossref","unstructured":"McDiarmid SV Millis MJ Terasaki PI Ament ME Busuttil RW OKT3 prophylaxis in liver transplantation Digestive Diseases and Sciences 1991 1418 26","DOI":"10.1007\/BF01296809"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0023|cit23","doi-asserted-by":"crossref","unstructured":"Millis JM McDiarmid SV Hiatt JR Brems JJ Colonna JO 2nd Klein AS Randomized prospective trial of OKT3 for early prophylaxis of rejection after liver transplantation Transplantation 1989 82 8","DOI":"10.1097\/00007890-198901000-00019"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0024|cit24","doi-asserted-by":"crossref","unstructured":"Nashan B Schlitt HJ Schwinzer R Ringe B Kuse E Tusch G Immunoprophylaxis with a monoclonal anti-IL-2 receptor antibody in liver transplant patients Transplantation 1996 546 54","DOI":"10.1097\/00007890-199602270-00006"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0966-3274(95)80026-3","article-title":"Immunological effects of the anti-IL-2 receptor monoclonal antibody BT 563 in liver allografted patients","volume":"3","author":"Nashan","year":"1995","journal-title":"Transplant Immunology"},{"issue":"2","key":"10.1002\/14651858.CD010253.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1600-6143.2008.02493.x","article-title":"Delayed introduction of reduced-dose tacrolimus, and renal function in liver transplantation: the 'ReSpECT' study","volume":"9","author":"Neuberger","year":"2009","journal-title":"American Journal of Transplantation"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0027|cit27","first-page":"536","article-title":"The monoclonal anti-IL 2 receptor antibody basiliximab reduces the incidence and degree of acute rejections after liver transplantation","volume":"38","author":"Nashan","year":"2000","journal-title":"Zeitschrift fur Gastroenterologie"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1053\/jlts.2002.30302","article-title":"Improved treatment response with basiliximab immunoprophylaxis after liver transplantation: results from a double-blind randomized placebo-controlled trial","volume":"8","author":"Neuhaus","year":"2002","journal-title":"Liver Transplantation"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0029|cit29","doi-asserted-by":"crossref","unstructured":"Neuhaus P Nashan B Clavin PA Kittur D Salizzoni M Rimola A Basiliximab (Simulect) reduces the rate and severity of acute rejection in adult liver transplant recipients [abstract] Liver Transplantation 2000 C 25","DOI":"10.1097\/00007890-200004271-00026"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0030|cit30","unstructured":"Otto G Hofmann WJ Gaweco AS Seelos R Herfarth C Meuer S Influence of the anti-CD25 monoclonal antibody BT563 on clinical and biological rejection after orthotopic liver transplantation Transplantation Proceedings 1996 3210 1"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1097\/00007890-199605150-00022","article-title":"Prophylactic immunosuppression with anti-interleukin-2 receptor monoclonal antibody LO-Tact-1 versus OKT3 in liver allografting. A two-year follow-up study","volume":"61","author":"Reding","year":"1996","journal-title":"Transplantation"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0032|cit32","doi-asserted-by":"crossref","unstructured":"Reding R Vraux H de Ville de Goyet J Sokal E de Hemptinne B Latinne D Monoclonal antibodies in prophylactic immunosuppression after liver transplantation. A randomized controlled trial comparing OKT3 and anti-IL-2 receptor monoclonal antibody LO-Tact-1 Transplantation 1993 534 41","DOI":"10.1097\/00007890-199303000-00015"},{"issue":"3","key":"10.1002\/14651858.CD010253.pub2-BIB0033|cit33","first-page":"15","article-title":"Influence of basiliximab induction therapy on long term outcome after liver transplantation, a prospectively randomised trial","volume":"12","author":"Schmeding","year":"2007","journal-title":"Annals of Transplantation"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0034|cit34","first-page":"C","article-title":"Induction with basiliximab reduces acute rejection in Chinese liver transplant recipients treated with cyclosporin, steroids and MMF","volume":"10","author":"Yan","year":"2004","journal-title":"Liver Transplantation"},{"issue":"9","key":"10.1002\/14651858.CD010253.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/lt.20490","article-title":"Evaluation of renal function in liver transplant recipients receiving daclizumab (Zenapax), mycophenolate mofetil, and a delayed, low-dose tacrolimus regimen vs. a standard-dose tacrolimus and mycophenolate mofetil regimen: a multicenter randomized clinical trial","volume":"11","author":"Yoshida","year":"2005","journal-title":"Liver Transplantation"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1111\/j.1600-6143.2010.03164.x","article-title":"ATG-Fresenius treatment and low-dose tacrolimus: results of a randomized controlled trial in liver transplantation","volume":"10","author":"Benitez","year":"2010","journal-title":"American Journal of Transplantation"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0037|cit37","doi-asserted-by":"crossref","unstructured":"Boillot O Mayer DA Boudjema K Salizzoni M Gridelli B Filipponi F Corticosteroid-free immunosuppression with tacrolimus following induction with daclizumab: a large randomized clinical study Liver Transplantation 2005 61 7","DOI":"10.1002\/lt.20307"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD010253.pub2-BIB0038|cit38","first-page":"33","article-title":"Results of a multicenter, randomized open-label, controlled clinical trial comparing basiliximab versus steroids in hepatitis C positive liver transplant patients","volume":"20","author":"Simone","year":"2007","journal-title":"Transplant International"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD010253.pub2-BIB0039|cit39","first-page":"312","article-title":"Results of a multicenter, randomized open-label trial comparing basiliximab vs. steroids in HCV liver transplant patients","volume":"7","author":"Simone","year":"2007","journal-title":"American Journal of Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD010253.pub2-BIB0040|cit40","first-page":"208A","article-title":"Steroid-free immunosuppression through thymoglobulin induction in liver transplantation: results of a prospective randomized trial","volume":"32","author":"Eason","year":"2000","journal-title":"Transplantation Proceedings"},{"issue":"8","key":"10.1002\/14651858.CD010253.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1053\/jlts.2001.26353","article-title":"Steroid-free liver transplantation using rabbit antithymocyte globulin induction: results of a prospective randomized trial","volume":"7","author":"Eason","year":"2001","journal-title":"Liver Transplantation"},{"issue":"8","key":"10.1002\/14651858.CD010253.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1097\/01.TP.0000062834.30922.FE","article-title":"Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy","volume":"75","author":"Eason","year":"2003","journal-title":"Transplantation"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/01.tp.0000181192.13836.8c","article-title":"Induction with rabbit antithymocyte globulin versus induction with corticosteroids in liver transplantation: impact on recurrent hepatitis C virus infection","volume":"81","author":"Nair","year":"2006","journal-title":"Transplantation"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/01.tp.0000282914.20578.7b","article-title":"Randomized trial of steroid-free induction versus corticosteroid maintenance among orthotopic liver transplant recipients with hepatitis C virus: impact on hepatic fibrosis progression at one year","volume":"84","author":"Kato","year":"2007","journal-title":"Transplantation"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0045|cit45","first-page":"362A","article-title":"Steroid-free induction with daclizumab and tacrolimus in liver transplant recipients with hepatitis C: a preliminary report [abstract]","volume":"34","author":"Kato","year":"2001","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/01.tp.0000282914.20578.7b","article-title":"Randomized trial of steroid-free induction versus corticosteroid maintenance among orthotopic liver transplant recipients with hepatitis C virus: impact on hepatic fibrosis progression at one year","volume":"84","author":"Kato","year":"2007","journal-title":"Transplantation"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0047|cit47","doi-asserted-by":"crossref","unstructured":"Kato T Yoshida H Sadfar K Martinez E Nishida S Moon J Steroid-free induction and preemptive antiviral therapy for liver transplant recipients with hepatitis C: a preliminary report from a prospective randomized study Hepatology 2005 1217 9","DOI":"10.1016\/j.transproceed.2004.12.042"},{"issue":"12","key":"10.1002\/14651858.CD010253.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1002\/lt.22417","article-title":"A randomized, multicenter study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C","volume":"17","author":"Klintmalm","year":"2011","journal-title":"Liver Transplantation"},{"issue":"11","key":"10.1002\/14651858.CD010253.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/lt.21182","article-title":"Corticosteroid-free immunosuppression with daclizumab in HCV(+) liver transplant recipients: 1-year interim results of the HCV-3 study","volume":"13","author":"Klintmalm","year":"2007","journal-title":"Liver Transplantation"},{"issue":"7","key":"10.1002\/14651858.CD010253.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1097\/TP.0b013e318186b8a3","article-title":"Basiliximab versus steroids in double therapy immunosuppression in liver transplantation: a prospective randomized clinical trial","volume":"86","author":"Lupo","year":"2008","journal-title":"Transplantation"},{"issue":"7","key":"10.1002\/14651858.CD010253.pub2-BIB0051|cit51","first-page":"LB17","article-title":"Basiliximab vs steroids in liver transplantation immunosuppression. A prospective randomized clinical trial","volume":"11","author":"Lupo","year":"2005","journal-title":"Liver Transplantation"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"894215","DOI":"10.1155\/2012\/894215","article-title":"A randomized multicenter study comparing a tacrolimus-based protocol with and without steroids in HCV-positive liver allograft recipients","volume":"2012","author":"Neumann","year":"2012","journal-title":"Journal of Transplantation"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0053|cit53","doi-asserted-by":"crossref","unstructured":"Spada M Bertani A Petz W Torri E Sonzogni A Guizzetti M A randomized trial for tacrolimus and steroids vs. tacrolimus and basiliximab in pediatric liver transplantation Hepatology 2004 473A","DOI":"10.1097\/00007890-200407271-01259"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0054|cit54","doi-asserted-by":"crossref","unstructured":"Spada M Petz W Bertani A Riva S Sonzogni A Giovannelli M Randomized trial of basiliximab induction versus steroid therapy in pediatric liver allograft recipients under tacrolimus immunosuppression American Journal of Transplantation 2006 1913 21","DOI":"10.1111\/j.1600-6143.2006.01406.x"},{"issue":"10","key":"10.1002\/14651858.CD010253.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1097\/00007890-200111270-00018","article-title":"Steroid elimination 24 hours after liver transplantation using daclizumab, tacrolimus, and mycophenolate mofetil","volume":"72","author":"Washburn","year":"2001","journal-title":"Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD010253.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1055\/s-2007-1007379","article-title":"Treatment of acute rejection","volume":"12","author":"Adams","year":"1992","journal-title":"Seminars in Liver Disease"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0057|cit57","doi-asserted-by":"crossref","unstructured":"Banff schema for grading liver allograft rejection: an international consensus document Hepatology 1997 658 63","DOI":"10.1002\/hep.510250328"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jclinepi.2007.10.007","article-title":"Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses","volume":"61","author":"Brok","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"issue":"8","key":"10.1002\/14651858.CD010253.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1432-2277.2008.00713.x","article-title":"The long and winding road towards induction of allograft tolerance in the clinic","volume":"21","author":"Chatenoud","year":"2008","journal-title":"Transplant International"},{"issue":"4","key":"10.1002\/14651858.CD010253.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/01.mot.0000236699.52834.6f","article-title":"Regulatory T-cell subsets and their roles in transplantation tolerance","volume":"11","author":"Chen","year":"2006","journal-title":"Current Opinion in Organ Transplantation"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0061|cit61","unstructured":"Copenhagen Trial Unit TSA - Trial Sequential Analysis ctu.dk\/tsa\/"},{"issue":"16","key":"10.1002\/14651858.CD010253.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1056\/NEJMp1210159","article-title":"Liver transplantation - a vision realized","volume":"367","author":"Dienstag","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"7109","key":"10.1002\/14651858.CD010253.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"17","key":"10.1002\/14651858.CD010253.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1056\/NEJM199410273311702","article-title":"A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation","volume":"331","author":"The U.S. Multicenter FK506 Liver Study Group","year":"1994","journal-title":"New England Journal of Medicine"},{"issue":"8920","key":"10.1002\/14651858.CD010253.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0140-6736(94)91766-3","article-title":"Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection","volume":"344","author":"European FK506 Multicentre Liver Study Group","year":"1994","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD010253.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0012.2007.00739.x","article-title":"Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity","volume":"22","author":"Flechner","year":"2008","journal-title":"Clinical Transplantation"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0067|cit67","doi-asserted-by":"crossref","unstructured":"Gluud C Nikolova D Klingenberg SL Alexakis N Als-Nielsen B Colli A Cochrane Hepato-Biliary Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)) 2014, Issue 1. Art. No.: LIVER","DOI":"10.1002\/14651858.CD009182.pub2"},{"issue":"2","key":"10.1002\/14651858.CD010253.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hep.24385","article-title":"Interleukin 2 receptor antagonists for liver transplant recipients: a systematic review and meta-analysis of controlled studies","volume":"54","author":"Goralczyk","year":"2011","journal-title":"Hepatology"},{"issue":"11","key":"10.1002\/14651858.CD010253.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0070|cit70","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] The Cochrane Collaboration, 2011. www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0071|cit71","volume-title":"International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice CFR & ICH Guidelines","volume":"1","author":"International Conference on Harmonisation Expert Working Group","year":"1997"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1183\/1025448x.00045012","article-title":"Immunosuppression","volume-title":"European Respiratory Monthly: Lung Transplantation","author":"Iversen","year":"2009"},{"issue":"3","key":"10.1002\/14651858.CD010253.pub2-BIB0073|cit73","first-page":"546","article-title":"Robustness assessments are needed to reduce bias in meta-analyses that include zero-event randomized trials","volume":"104","author":"Keus","year":"2009","journal-title":"American Journal of Gastroenterology"},{"issue":"11","key":"10.1002\/14651858.CD010253.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD010253.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nm1251","article-title":"Organ transplantation - how much of the promise has been realized?","volume":"11","author":"Lechler","year":"2005","journal-title":"Nature Medicine"},{"issue":"12","key":"10.1002\/14651858.CD010253.pub2-BIB0076|cit76","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.MR000033.pub2","article-title":"Industry sponsorship and research outcome","author":"Lundh","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD010253.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/sim.698","article-title":"A comparison of methods to detect publication bias in meta-analysis","volume":"20","author":"Macaskill","year":"2001","journal-title":"Statistics in Medicine"},{"issue":"9","key":"10.1002\/14651858.CD010253.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1432-2277.2006.00343.x","article-title":"The evolving role of alemtuzumab (Campath-1H) for immunosuppressive therapy in organ transplantation","volume":"19","author":"Magliocca","year":"2006","journal-title":"Transplant International"},{"issue":"7","key":"10.1002\/14651858.CD010253.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1097\/01.TP.0000142674.78268.01","article-title":"Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus","volume":"78","author":"Marcos","year":"2004","journal-title":"Transplantation"},{"issue":"9128","key":"10.1002\/14651858.CD010253.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"issue":"7","key":"10.1002\/14651858.CD010253.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"995","DOI":"10.2165\/00003495-200262070-00002","article-title":"Options for induction immunosuppression in liver transplant recipients","volume":"62","author":"Moser","year":"2002","journal-title":"Drugs"},{"issue":"6","key":"10.1002\/14651858.CD010253.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1097\/00007890-199306000-00021","article-title":"Comparison of quadruple immunosuppression after liver transplantation with ATG or IL-2 receptor antibody","volume":"55","author":"Neuhaus","year":"1993","journal-title":"Transplantation"},{"issue":"9340","key":"10.1002\/14651858.CD010253.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(02)11196-2","article-title":"Tacrolimus versus microemulsified ciclosporin in liver transplantation: the TMC randomised controlled trial","volume":"360","author":"O'Grady","year":"2002","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0084|cit84","unstructured":"OPTN \/ SRTR Annual Report The U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients www.ustransplant.org\/annual_reports\/current\/"},{"issue":"3","key":"10.1002\/14651858.CD010253.pub2-BIB0085|cit85","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008852.pub2","article-title":"Calcineurin inhibitor minimisation versus continuation of calcineurin inhibitor treatment for liver transplant recipients","author":"Penninga","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD010253.pub2-BIB0086|cit86","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008927.pub2","article-title":"Antibody induction therapy for lung transplant recipients","author":"Penninga","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD010253.pub2-BIB0087|cit87","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008842.pub2","article-title":"Immunosuppressive T-cell antibody induction for heart transplant recipients","author":"Penninga","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD010253.pub2-BIB0088|cit88","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010252.pub2","article-title":"Antibody induction versus corticosteroid induction for liver transplant recipients","author":"Penninga","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0089|cit89","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-013-2264-8","article-title":"Meta-analysis of randomised trials on laparoscopic versus open surgery for acute appendicitis: has firm evidence been reached?","author":"Pennnga","year":"2014","journal-title":"Journal of Gastrointestinal Surgery"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD010253.pub2-BIB0090|cit90","first-page":"S124","article-title":"Liver transplantation: issues for the next 20 years","volume":"24","author":"Perera","year":"2009","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"34","key":"10.1002\/14651858.CD010253.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.3748\/wjg.15.4225","article-title":"Overview of immunosuppression in liver transplantation","volume":"15","author":"Pillai","year":"2009","journal-title":"World Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0092|cit92","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2012"},{"issue":"4","key":"10.1002\/14651858.CD010253.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1017\/S0266462303000552","article-title":"Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches","volume":"19","author":"Royle","year":"2003","journal-title":"International Journal of Technology Assessment in Health Care"},{"issue":"35","key":"10.1002\/14651858.CD010253.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta16350","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials","volume":"16","author":"Savovi\u0107","year":"2012","journal-title":"Health Technology Assessment"},{"issue":"6","key":"10.1002\/14651858.CD010253.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-157-6-201209180-00537","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials","volume":"157","author":"Savovi\u0107","year":"2012","journal-title":"Annals of Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD010253.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.pcl.2010.01.015","article-title":"Tolerance: is it achievable in pediatric solid organ transplantation?","volume":"57","author":"Seyfert-Margolis","year":"2010","journal-title":"Pediatric Clinics of North America"},{"issue":"9","key":"10.1002\/14651858.CD010253.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/j.1432-2277.2009.00893.x","article-title":"Corticosteroid-free immunosuppression in liver transplantation: a meta-analysis and meta-regression of outcomes","volume":"22","author":"Sgourakis","year":"2009","journal-title":"Transplant International"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","article-title":"SPIRIT 2013 Statement: defining standard protocol items for clinical trials","volume":"158","author":"Chan","year":"2013","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0100|cit100","first-page":"e7586","article-title":"SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials","volume":"346","author":"Chan","year":"2013","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0101|cit101","doi-asserted-by":"crossref","unstructured":"Starzl TE Murase N Abu-Elmagd K Gray EA Shapiro R Eghtesad B Tolerogenic immunosuppression for organ transplantation Lancet 2003 1502 10","DOI":"10.1016\/S0140-6736(03)13175-3"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0102|cit102","doi-asserted-by":"crossref","unstructured":"Starzl TE Immunosuppressive therapy and tolerance of organ allografts New England Journal of Medicine 2008 407 11","DOI":"10.1056\/NEJMe0707578"},{"issue":"9","key":"10.1002\/14651858.CD010253.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/sim.1761","article-title":"What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data","volume":"23","author":"Sweeting","year":"2004","journal-title":"Statistics in Medicine"},{"issue":"11","key":"10.1002\/14651858.CD010253.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/sim.1187","article-title":"How should meta-regression analyses be undertaken and interpreted?","volume":"21","author":"Thompson","year":"2002","journal-title":"Statistics in Medicine"},{"issue":"1","key":"10.1002\/14651858.CD010253.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/ije\/dyn179","article-title":"Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses","volume":"38","author":"Thorlund","year":"2009","journal-title":"International Journal of Epidemiology"},{"issue":"10","key":"10.1002\/14651858.CD010253.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"e25491","DOI":"10.1371\/journal.pone.0025491","article-title":"The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysisa simulation study","volume":"6","author":"Thorlund","year":"2011","journal-title":"PLoS One"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0107|cit107","unstructured":"Thorlund K Engstr\u00f8m J Wetterslev J Brok J Imberger G Gluud C User manual forTrial Sequential Analysis (TSA) ctu.dk\/tsa\/files\/tsa_manual.pdf"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0108|cit108","unstructured":"Transplant activity report 2008\/2009 UK www.organdonation.nhs.uk\/ukt\/statistics\/statistics.jsp"},{"issue":"7","key":"10.1002\/14651858.CD010253.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/j.1432-2277.2011.01250.x","article-title":"Outcome of induction immunosuppression for liver transplantation comparing anti-thymocyte globulin, daclizumab, and corticosteroid","volume":"24","author":"Uemura","year":"2011","journal-title":"Transplant International"},{"issue":"10","key":"10.1002\/14651858.CD010253.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1016\/j.transproceed.2010.09.169","article-title":"Interleukin-2 receptor antagonists in liver transplantation: a meta-analysis of randomized trials","volume":"42","author":"Wang","year":"2010","journal-title":"Transplantation Proceedings"},{"issue":"1","key":"10.1002\/14651858.CD010253.pub2-BIB0111|cit111","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003897.pub3","article-title":"Interleukin 2 receptor antagonists for kidney transplant recipients","author":"Webster","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD010253.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"Wetterslev","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2288-9-86","article-title":"Estimating required information size by quantifying diversity in random-effects model meta-analyses","volume":"9","author":"Wetterslev","year":"2009","journal-title":"BMC Medical Research Methodology"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0114|cit114","doi-asserted-by":"crossref","unstructured":"Wiesner RH Rakela J Ishitani MB Mulligan DC Spivey JR Steers JL Recent advances in liver transplantation Mayo Clinic Proceedings 2003 197 210","DOI":"10.4065\/78.2.197"},{"key":"10.1002\/14651858.CD010253.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood","year":"2008","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"11, 2011 - 10,","key":"10.1002\/14651858.CD010253.pub2-BIB0116|cit116","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007341.pub2","article-title":"Immunosuppressive T cell antibody induction therapy for liver transplant recipients","author":"Penninga","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3, 2008 - 10, 2","key":"10.1002\/14651858.CD010253.pub2-BIB0117|cit117","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007341","article-title":"Immunosuppressive T cell antibodies for liver transplant recipients","author":"Wilson","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD010253.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T03:19:41Z","timestamp":1746242381000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010253.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Hepato-Biliary Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,6,5]]},"references-count":117,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2014,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010253.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,5]]}}}